0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Advanced Biomedical Technologies
Its shares trade under the ticker ABMT. It has been listed since 10 September 2007. In the fiscal year to 31 October 2022, it reported revenue of $270,991 and a net loss of $515,485. At that date it held total assets of $395,704 and shareholders' equity of −$7.9m.
Advanced BioMedical Technologies, Inc. engages in the provision of medical and pain management tools. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The firm's primary products include absorbable polyamide (PA) osteosynthesis devices made of a PA material. These advanced materials are used in surgical screws, binding wires, rods and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials, and its PA Mini-Screws are under animal test. The firm's PA products, such as screws, rods, and binding wires, consist of fibers and high molecular polymers, which are designed to facilitate healing of complex fractures in many areas of the human skeletal system. As of October 31, 2016, the Company had completed the design and production of testing mini-screws using its PA material.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 10 Sept 2007
- Employees
- 24
Leadership
Pay as last reported
- Mr. Chiming YuPresident, Director, since 2008$15,300
- Ms. Hui WangChief Executive Officer, Director, since 2009$34,602
- Mr. Kai GuiChief Financial Officer, Chief Operating Officer, Secretary, Director$22,950
- Prof. Puyi ShengChief Medical Officer$4,200
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Advanced Biomedical Technologies Inc has a strong reputation in the biomedical industry due to its innovative products and advanced technologies.
- The company has a talented team of researchers and scientists who consistently deliver high-quality results.
- Advanced Biomedical Technologies Inc has established strong partnerships with leading universities and research institutions, allowing access to cutting-edge research and expertise.
Weaknesses
- The company heavily relies on external funding for its research and development projects, making it vulnerable to funding fluctuations.
- Advanced Biomedical Technologies Inc has a relatively small market share compared to its larger competitors, limiting its bargaining power and market influence.
- The company currently lacks a diverse product portfolio, which may hinder its ability to capitalize on multiple market segments.
Opportunities
- The growing demand for advanced medical technologies presents a significant opportunity for Advanced Biomedical Technologies Inc to expand its market presence.
- Advancements in 3D printing and other emerging technologies provide potential avenues for the development of new and innovative products.
- The increasing focus on personalized medicine creates an opportunity for Advanced Biomedical Technologies Inc to develop customized solutions for individual patients.
Threats
- Intense competition from larger and more established companies poses a threat to Advanced Biomedical Technologies Inc's market position.
- Changes in regulatory policies and compliance requirements may impact the company's ability to bring products to market efficiently.
- Global economic uncertainties and fluctuations in currency exchange rates could affect the company's financial stability and international operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.